Kyushu University Academic Staff Educational and Research Activities Database
Researcher information (To researchers) Need Help? How to update
Koyanagi Satoru Last modified date:2024.04.29

Undergraduate School
Other Organization
Administration Post
Dean of the Faculty of Pharmaceutical Sciences

E-Mail *Since the e-mail address is not displayed in Internet Explorer, please use another web browser:Google Chrome, safari.
 Reseacher Profiling Tool Kyushu University Pure
Laboratory of Pharmaceutics .
Academic Degree
Field of Specialization
Pharmaceutics, Chronopharmacotherapy
ORCID(Open Researcher and Contributor ID)
Total Priod of education and research career in the foreign country
Outline Activities
Recent developments in our understanding of circadian biology and the availability of tools to characterize this oscillation system indicate that the choosing appropriate dosing time have consequences for the ef cacy and safety of new and existing therapeutic drugs (Chronopharmacotherapy). Progression of this research eld also suggests that many pathological conditions are under the control of the circadian clock. These notions reveal opportunities for new therapeutic strategies. Now novel therapeutic approaches are facilitated by development of chemical probes and synthetic ligands targeted to an increasing number of the key proteins that causing circadian exacerbation of pathological events.
The major objective of our research is to understand the molecular mechanisms for day-night changes in the pathological events and the impact of circadian rhythms on the onset of diseases. Based on these mechanism, we attempt to identify new therapeutic target and to develop novel strategy for treatment of diseases.
Research Interests
  • Investigation of underlying mechanism of circadian variations in the function of pharmacokinetic regulatory factor by RNA editting
    keyword : RNA editting, pharmacokinetic regulatory factor, circadian rhythm
  • Study on the role of circadian clock gene in the oncogenic transformation
    keyword : Clock genes, Cellular oncogenic transformation
  • Study on the mechanism for circadian regulation of intractable pain
    keyword : Neuropathic pain , Cancer, Circadian rhythm
  • Development of chronopharmacotherapy of anti-cancer drug based on molecular circadian clock
    keyword : Biological rhythm, clock gene, cell cycle
  • Evaluation of the mechanism of circadian time-dependent change of drug efficacy and development of chronodrug delivery system
    keyword : target molecule, drug metabolism, transporter
Academic Activities
1. Koyanagi S, Kusunose N, Matsunaga N, Ohdo S., Biological Clock with reference to suprachiasmatic nucleus, 北海道大学出版会, 2017.11.
2. Soeda S., Koyanagi S., Shimeno H., Angiogenesis; Functional and Medicinal Foods, Marcel Decker N.Y., 2007.04.
1. Koyanagi S, Kusunose N, Yasukochi S, Ohdo S., Basis for diurnal exacerbation of neuropathic pain hypersensitivity and its application for drug development, J Biochem, 10.1093/jb/mvab143, 2021.11.
2. Ohdo S, Koyanagi S, Matsunaga N, Chronopharmacological strategies focused on chrono-drug discovery, 10.1016/j.pharmthera.2019.05.018, 2021.05.
3. Ohdo S, Koyanagi S, Matsunaga N., Chronopharmacological strategies: Intra- and inter-individual variability of molecular clock, Adv Drug Deliv Rev, 2010.06.
1. Yamakawa W, Yasukochi S, Tsurudome Y, Kusunose N, Yamaguchi Y, Tsuruta A, Matsunaga N, Ushijima K, Koyanagi S, Ohdo S, Suppression of neuropathic pain in the circadian clock-deficient Per2m/m mice involves up-regulation of endocannabinoid system, PNAS Nexus, 10.1093/pnasnexus/pgad482, 3, pgad483, 2024.01.
2. Omata Y, Okawa M, Haraguchi M, Tsuruta A, Matsunaga N, Koyanagi S, Ohdo S, RNA editing enzyme ADAR1 controls miR-381-3p-mediated expression of multidrug resistance protein MRP4 via regulation of circRNA in human renal cells, J Biol Chem, 298, 102184, 2022.07.
3. Omata Y, Yamauchi T, Tsuruta A, Matsunaga N, Koyanagi S, Ohdo S, RNA editing enzyme ADAR1 governs the circadian expression of P-glycoprotein in human renal cells by regulating alternative splicing of the ABCB1 gene, J Biol Chem, 10.1016/j.jbc.2021.100601, 298, 100601, 2021.04.
4. Koyanagi S, Kusunose N, Taniguchi M, Akamine T, Kanado Y, Ozono Y, Masuda T, Kohro Y, Matsunaga N, Tsuda M, Salter MW, Inoue K, Ohdo S, Glucocorticoid regulation of ATP release from spinal astrocytes underlies diurnal exacerbation of neuropathic mechanical allodynia, Nature Commun., 7, 2016.10.
5. Katamune C, Koyanagi S, Shiromizu S, Matsunaga N, Shimba S, Shibata S, Ohdo S, Different roles of negative and positive components of the circadian clock in oncogene-induced neoplastic transformation, J Biol Chem, 291, 2016.05.
6. Horiguchi M, Koyanagi S, Hamdan AM, Kakimoto K, Matsunaga N, Yamashita C, Ohdo S., Rhythmic Control of the ARF-MDM2 Pathway by ATF4 Underlies Circadian Accumulation of p53 in Malignant Cells, Cancer Res, 8, 2013.04.
7. Hamdan AM, Koyanagi S, Wada E, Kusunose N, Murakami Y, Matsunaga N, Ohdo S., Intestinal Expression of Mouse Abcg2/Breast Cancer Resistance Protein (BCRP) Gene Is under Control of Circadian Clock-activating Transcription Factor-4 Pathway, J Biol Chem, 21, 17224-17231, 2012.05.
8. Horiguchi M, Koyanagi S, Okamoto A, Suzuki SO, Matsunaga N, Ohdo S., Stress-regulated transcription factor ATF4 promotes neoplastic transformation by suppressing expression of the INK4a/ARF cell senescence factors, Cancer Res., 72, 395-401, 2011.11.
9. Koyanagi S, Hamdan AM, Horiguchi M, Kusunose N, Okamoto A, Matsunaga N, Ohdo S., cAMP response element-mediated transcription by activating transcription factor-4 (ATF4) is essential for circadian expression of the Period2 gene., J Biol Chem., 286, 32416-32423, 2011.07.
10. Murakami Y, Higashi Y, Matsunaga N, Koyanagi S, Ohdo S, Circadian clock-controlled intestinal expression of the multidrug-resistance gene mdr1a in mice, Gastroenterology, 135, 1636-1644, 2008.08.
11. Takiguchi T., Tomita M., Matsunaga N., Nakagawa H., Koyanagi S., and Ohdo S., Molecular basis for rhythmic expression of CYP3A4 in serum-shocked HepG2 cells, Pharmacogenet. Genomics, 17, 1047-1056, 2007.12.
12. Koyanagi S., Kuramoto Y., Nakagawa H., Aramaki H., Ohdo S., Soeda S., Shimeno H., A molecular mechanism regulating circadian expression of vascular endothelial growth factor in tumor cells, Cancer Res., 21, 7277-7283, 2003.11.
13. Ohdo S., Koyanagi S., Suyama H., Higuchi S., Aramaki H., Changing the dosing schedule minimizes the disruptive effects of interferon on clock function., Nature Medicine, 3, 354-360, 2001.03.
1. Koyanagi S., Circadian clock and Chronopharmacology, Annual Meeting Taiwan Pharmaceutical Society, 2020.11.
2. Satoru Koyanagi, Glucocorticoid regulation of ATP release from spinal astrocytes underlies diurnal exacerbation of pain hypersensitivity after peripheral nerve injury, Sapporo Symposium on Biological Rhythm in 2016, 2016.11.
3. Koyanagi Satoru, Shigehiro Ohdo, Molecular basis for circadian sensitivity of tumor cells to chemotherapeutic agents, Spring Annual Convention of Pharmaceutical Society of Korea, 2014.04.
4. Molecular machanim for the circadian expression of intestinal transporters.
Membership in Academic Society
  • The Japanese Pharmacological Society
  • The Japanese Society for Alternatives to Animal Experiments
  • Chrono-pharmaceutical study based on the molecular mechanism of circadian rhythms in
    pathological condition and drug efficacy
  • Chronopharmacokinetic study based on molecular circadian clock
Other Educational Activities
  • 2022.04.
  • 2022.04.
  • 2021.04.
  • 2021.04.
  • 2020.04.
  • 2019.04.
  • 2018.04.
  • 2017.04.
  • 2016.04.